Compare PDSB & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDSB | VHC |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | United States |
| Employees | 10 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.4M | 46.0M |
| IPO Year | 2015 | 2008 |
| Metric | PDSB | VHC |
|---|---|---|
| Price | $0.81 | $12.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 41.8M | 112.0K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.16 | 0.99 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $162,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3140.00 |
| 52 Week Low | $0.20 | $9.82 |
| 52 Week High | $1.55 | $29.00 |
| Indicator | PDSB | VHC |
|---|---|---|
| Relative Strength Index (RSI) | 81.39 | 42.33 |
| Support Level | $0.81 | $10.84 |
| Resistance Level | $1.11 | $18.44 |
| Average True Range (ATR) | 0.11 | 0.92 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 81.35 | 41.41 |
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. Its software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.